Ayus Juan Carlos, Moritz Michael L, Fuentes Nora Angélica, Mejia Jhonatan R, Alfonso Juan Martín, Shin Saeha, Fralick Michael, Ciapponi Agustín
Division of Nephrology, Hypertension, and Kidney Transplantation, Department of Medicine, University of California, Irvine School of Medicine, Irvine.
Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
JAMA Intern Med. 2025 Jan 1;185(1):38-51. doi: 10.1001/jamainternmed.2024.5981.
Hyponatremia treatment guidelines recommend limiting the correction of severe hyponatremia during the first 24 hours to prevent osmotic demyelination syndrome (ODS). Recent evidence suggests that slower rates of correction are associated with increased mortality.
To evaluate the association of sodium correction rates with mortality among hospitalized adults with severe hyponatremia.
We searched MEDLINE, Embase, the Cochrane Library, LILACS, Web of Science, CINAHL, and international congress proceedings for studies published between January 2013 and October 2023.
Comparative studies assessing rapid (≥8-10 mEq/L per 24 hours) vs slow (<8 or 6-10 mEq/L per 24 hours) and very slow (<4-6 mEq/L per 24 hours) correction of severe hyponatremia (serum sodium <120 mEq/L or <125 mEq/L plus severe symptoms) in hospitalized patients.
Pairs of reviewers (N.A.F., J.R.M., J.M.A., A.C.) independently reviewed studies, extracted data, and assessed each included study's risk of bias using ROBINS-I. Cochrane methods, PRISMA reporting guidelines, and the GRADE (Grading of Recommendations Assessment, Development and Evaluation) approach to rate the certainty of evidence were followed. Data were pooled using a random-effects model.
Primary outcomes were in-hospital and 30-day mortality, and secondary outcomes were hospital length of stay (LOS) and ODS.
Sixteen cohort studies involving a total of 11 811 patients with severe hyponatremia were included (mean [SD] age, 68.22 [6.88] years; 56.7% female across 15 studies reporting sex). Moderate-certainty evidence showed that rapid correction was associated with 32 (odds ratio, 0.67; 95% CI, 0.55-0.82) and 221 (odds ratio, 0.29; 95% CI, 0.11-0.79) fewer in-hospital deaths per 1000 treated patients compared with slow and very slow correction, respectively. Low-certainty evidence suggested that rapid correction was associated with 61 (risk ratio, 0.55; 95% CI, 0.45-0.67) and 134 (risk ratio, 0.35; 95% CI, 0.28-0.44) fewer deaths per 1000 treated patients at 30 days and with a reduction in LOS of 1.20 (95% CI, 0.51-1.89) and 3.09 (95% CI, 1.21-4.94) days, compared with slow and very slow correction, respectively. Rapid correction was not associated with a statistically significant increased risk of ODS.
In this systematic review and meta-analysis, slow correction and very slow correction of severe hyponatremia were associated with an increased risk of mortality and hospital LOS compared to rapid correction.
低钠血症治疗指南建议在最初24小时内限制严重低钠血症的纠正速度,以预防渗透性脱髓鞘综合征(ODS)。近期证据表明,较慢的纠正速度与死亡率增加相关。
评估严重低钠血症住院成人患者钠纠正速度与死亡率之间的关联。
我们检索了MEDLINE、Embase、Cochrane图书馆、LILACS、科学网、CINAHL以及国际会议论文集,以获取2013年1月至2023年10月发表的研究。
评估住院患者严重低钠血症(血清钠<120 mEq/L或<125 mEq/L且伴有严重症状)快速(≥8 - 10 mEq/L每24小时)与缓慢(<8或6 - 10 mEq/L每24小时)及极缓慢(<4 - 6 mEq/L每24小时)纠正情况的比较研究。
由两位评审员(N.A.F.、J.R.M.、J.M.A.、A.C.)独立审查研究、提取数据,并使用ROBINS - I评估每项纳入研究的偏倚风险。遵循Cochrane方法、PRISMA报告指南以及GRADE(推荐分级评估、制定与评价)方法来评估证据的确定性。使用随机效应模型对数据进行汇总。
主要结局为住院期间及30天死亡率,次要结局为住院时间(LOS)和ODS。
纳入了16项队列研究,共涉及11811例严重低钠血症患者(平均[标准差]年龄,68.22[6.88]岁;15项报告性别的研究中56.百分之7女性)。中等确定性证据表明,与缓慢及极缓慢纠正相比,快速纠正每1000例接受治疗的患者住院期间死亡人数分别减少32例(比值比,0.67;95%置信区间,0.55 - 0.82)和221例(比值比,0.29;95%置信区间,0.11 - 0.79)。低确定性证据表明,与缓慢及极缓慢纠正相比,快速纠正每1000例接受治疗的患者在30天时死亡人数分别减少61例(风险比,0.55;95%置信区间,0.45 - 0.67)和134例(风险比,0.35;95%置信区间,0.28 - 0.44),且住院时间分别缩短1.20天(95%置信区间)。